Detecting Differential Transmissibilities That Affect the Size of Self-Limited Outbreaks

PLoS Pathogens

Volumn 10, Issue 10, 2014, Pages

  Blumberg, Seth ^a,b   Funk, Sebastian ^c,d   Pulliam, Juliet R C ^b,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d PRINCETON UNIVERSITY   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CORONAVIRUS; DISEASE CONTROL; DISEASE SEVERITY; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; EXPERIMENTAL MODEL; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION; INFORMATION PROCESSING; MEASLES; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MONKEYPOX VIRUS; NONHUMAN; PATHOGENESIS; PUBLIC HEALTH; RISK ASSESSMENT; SMALLPOX VIRUS; STATISTICAL ANALYSIS; VACCINATION; BIOLOGICAL MODEL; CORONAVIRUS INFECTIONS; DEMOCRATIC REPUBLIC CONGO; EPIDEMIC; EUROPE; MARKOV CHAIN; MIDDLE EAST; MONKEYPOX; NORTH AMERICA; SMALLPOX; TRANSMISSION;

CORONAVIRUS INFECTIONS; DEMOCRATIC REPUBLIC OF THE CONGO; DISEASE OUTBREAKS; EUROPE; HUMANS; MEASLES; MIDDLE EAST; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MODELS, BIOLOGICAL; MONKEYPOX; NORTH AMERICA; SMALLPOX; STOCHASTIC PROCESSES; VACCINATION;

EID: 84908340246     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004452     Document Type: Article

References (65)

1. De Serres G, Gay NJ, Farrington CP, (2000) Epidemiology of transmissible diseases after elimination. The American Journal of Epidemiology 151: 1039–1048.
2. Farrington CP, Kanaan MN, Gay NJ, (2003) Branching process models for surveillance of infectious diseases controlled by mass vaccination. Biostatistics 4: 279–295.
3. Jansen Vaa, Stollenwerk N, Jensen HJ, Ramsay ME, Edmunds WJ, et al. (2003) Measles outbreaks in a population with declining vaccine uptake. Science 301: 804.
4. Woolhouse M, Gowtage-Sequeria S, (2005) Host range and emerging and reemerging pathogens. Emerging Infectious Diseases 11: 1842–1847.
5. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, et al. (2008) Global trends in emerging infectious diseases. Nature 451: 990–993.
6. Lloyd-Smith JO, George D, Pepin KM, Pitzer VE, Pulliam JRC, et al. (2009) Epidemic dynamics at the human-animal interface. Science 326: 1362–1367.
7. Omer SB, Salmon DA, Orenstein WA, deHart MP, Halsey N, (2009) Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. New England Journal of Medicine 360: 1981–1988.
8. Antia R, Regoes RR, Koella JC, Bergstrom CT, (2003) The role of evolution in the emergence of infectious diseases. Nature 426: 8–11.
9. Arinaminpathy N, McLean AR, (2009) Evolution and emergence of novel human infections. Proceedings of the Royal Society B: Biological Sciences 276: 3937–3943.
10. Pepin KM, Lass S, Pulliam JRC, Read AF, Lloyd-Smith JO, (2010) Identifying genetic markers of adaptation for surveillance of viral host jumps. Nature Reviews Microbiology 8: 802–813.
11. Funk S, Salath M, Jansen VAA, (2010) Modelling the influence of human behaviour on the spread of infectious diseases: a review. Journal of The Royal Society Interface 7: 1247–1256.
12. Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID (1988) Smallpox and its Eradication. Geneva: World Health Organization, 1460 pp.
13. O'Reilly KM, Durry E, ul Islam O, Quddus A, Abid N, et al. (2012) The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in pakistan and afghanistan, 2001–11: a retrospective analysis. The Lancet 380: 491–498.
14. Minor PD, (2012) Polio vaccines and the eradication of poliomyelitis. The Lancet 380: 454–455.
15. Matthews L, Woolhouse M, (2005) New approaches to quantifying the spread of infection. Nature reviews Microbiology 3: 529–536.
16. Grassly NC, Fraser C, (2008) Mathematical models of infectious disease transmission. Nature reviews Microbiology 6: 477–487.
17. Lipsitch M, Cohen T, Cooper B, Robins JM, Ma S, et al. (2003) Transmission dynamics and control of severe acute respiratory syndrome. Science 300: 1966–1970.
18. Harbarth S, Samore MH, (2005) Antimicrobial resistance determinants and future control. Emerging infectious diseases 11: 794–801.
19. Blumberg S, Lloyd-Smith JO, (2013) Comparing methods for estimating R0 from the size distribution of subcritical transmission chains. Epidemics 5: 131–145.
20. Blumberg S, Lloyd-Smith JO, (2013) Inference of R0 and Transmission Heterogeneity from the Size Distribution of Stuttering Chains. PLoS Computational Biology 9: e1002993.
21. Diekmann O, Heesterbeek H, Britton T (2012) Mathematical Tools for Understanding Infectious Disease Dynamics. Princeton, New Jersey: Princeton University Press, 520 pp.
22. Nishiura H, Yan P, Sleeman CK, Mode CJ, (2012) Estimating the transmission potential of supercritical processes based on the final size distribution of minor outbreaks. Journal of Theoretical Biology 294: 48–55.
23. Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM, (2005) Superspreading and the effect of individual variation on disease emergence. Nature 438: 355–359.
24. van Boven M, Koopmans M, Du Ry van Beest Holle M, Meijer A, Klinkenberg D, et al. (2007) Detecting emerging transmissibility of avian influenza virus in human households. PLoS Comput Biol 3: e145.
25. Alexander HK, Day T, (2010) Risk factors for the evolutionary emergence of pathogens. Journal of the Royal Society, Interface 7: 1455–1474.
26. Harris TE (2002) The Theory of Branching Processes. Toronto: Dover, 256 pp.
27. Wilf HS (1990) generatingfunctionology. Academic Press, London.
28. Lange K (2010) Applied Probability. New York: Springer, second edition, 452 pp.
29. Anderson RM, May RM (1991) Infectious Diseases of Humans: Dynamics and Control. New York: Oxford University Press, 768 pp.
30. Bolker BM (2008) Ecological Models and Data in R. Princeton, New Jersey: Princeton University Press, 408 pp.
31. Akaike HAI, (1974) A New Look at the Statistical Model Identification. IEEE Transactions on Automatic Control 9: 716–723.
32. World Health Organization (2014) Update 15: summary and literature update as of 9 May 2014. URL http://www.who.int/csr/disease/coronavirus_infections/archive_updates/en/.
33. Breban R, Riou J, Fontanet A, (2013) Interhuman transmissibility of middle east respiratory syndrome coronavirus: estimation of pandemic risk. The Lancet 382: 694–699.
34. Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, et al. (2014) Middle east respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. The Lancet infectious diseases 14: 50–56.
35. Ferguson NM, Van Kerkhove MD, (2014) Identification of mers-cov in dromedary camels. The Lancet infectious diseases 14: 93–94.
36. Harpaz R, Papania MJ, McCauley MM, Redd SB, (2004) Has surveillance been adequate to detect endemic measles in the United States? The Journal of infectious diseases 189 SupplS191–S195.
37. Guris D, Harpaz R, Redd SB, Smith NJ, Papania MJ, (2004) Measles surveillance in the United States: an overview. The Journal of infectious diseases 189: S177–S184.
38. De Serres G, Markowski F, Toth E, Landry M, Auger D, et al. (2013) Largest measles epidemic in North America in a decade–Quebec, Canada, 2011: contribution of susceptibility, serendipity, and superspreading events. The Journal of infectious diseases 207: 990–998.
39. Gay NJ, De Serres G, Farrington CP, Redd SB, J M, (2004) Assessment of the status of measles elimination from reported outbreaks: United States, 1997–1999. The Journal of Infectious Diseases 189 SupplS36–S42.
40. King A, Varughese P, De Serres G, Tipples GA, Waters J, et al. (2004) Measles elimination in Canada. The Journal of Infectious Diseases 189 SupplS236–S242.
41. Centers for Disease Control and Prevention (2012). Documentation and verification of measles, rubella, and congenital rubella syndrome elimination in the region of the Americas.
42. Jezek Z, Fenner F (1988) Human Monkeypox. Basel: Karger, 140 pp.
43. Fine PE, Jezek Z, Grab B, Dixon H, (1988) The transmission potential of monkeypox virus in human populations. International Journal of Epidemiology 17: 643–650.
44. Rohani P, Zhong X, King Aa, (2010) Contact network structure explains the changing epidemiology of pertussis. Science (New York, NY) 330: 982–985.
45. Cauchemez S, Bhattarai A, Marchbanks TL, Fagan RP, Ostroff S, et al. (2011) Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza. Proceedings of the National Academy of Sciences of the United States of America 108: 2825–2830.
46. Danon L, Ford AP, House T, Jewell CP, Keeling MJ, et al. (2011) Networks and the epidemiology of infectious disease. Interdisciplinary perspectives on infectious diseases 2011: 284909.
47. Volz EM, Miller JC, Galvani A, Ancel Meyers L, (2011) Effects of heterogeneous and clustered contact patterns on infectious disease dynamics. PLoS computational biology 7: e1002042.
48. Cauchemez S, Ferguson NM, (2012) Methods to infer transmission risk factors in complex outbreak data. Journal of the Royal Society, Interface/the Royal Society 9: 456–469.
49. Jezek Z, Grab B, Dixon H, (1987) Stochastic model for interhuman spread of monkeypox. American Journal of Epidemiology 126: 1082–1092.
50. Woolhouse MEJ, (2002) Population biology of emerging and re-emerging pathogens. Trends in microbiology 10: S3–S7.
51. Yang Y, Halloran ME, Sugimoto JD, Longini IM, (2007) Detecting human-to-human transmission of avian influenza A (H5N1). Emerging infectious diseases 13: 1348–1353.
52. Streicker DG, Turmelle AS, Vonhof MJ, Kuzmin IV, McCracken GF, et al. (2010) Host phylogeny constrains cross-species emergence and establishment of rabies virus in bats. Science 329: 676–679.
53. Roy S, McElwain TF, Wan Y, (2011) A network control theory approach to modeling and optimal control of zoonoses: case study of brucellosis transmission in sub-Saharan Africa. PLoS neglected tropical diseases 5: e1259.
54. Aditama TY, Samaan G, Kusriastuti R, Sampurno OD, Purba W, et al. (2012) Avian influenza h5n1 transmission in households, indonesia. PloS one 7: e29971.
55. Funk S, Nishiura H, Heesterbeek H, Edmunds WJ, Checchi F, (2013) Identifying transmission cycles at the human-animal interface: the role of animal reservoirs in maintaining gambiense human african trypanosomiasis. PLoS computational biology 9: e1002855.
56. Rimoin AW, Mulembakani PM, Johnston SC, Smith JOL, Kisalu NK, et al. (2010) Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proceedings of the National Academy of Sciences of the United States of America 107: 16262–16267.
57. Lloyd-Smith JO, (2013) Vacated niches, competitive release and the community ecology of pathogen eradication. Philosophical Transactions of the Royal Society B: Biological Sciences 368: 20120150.
58. Fuller T, Thomassen Ha, Mulembakani PM, Johnston SC, Lloyd-Smith JO, et al. (2011) Using remote sensing to map the risk of human monkeypox virus in the Congo Basin. EcoHealth 8: 14–25.
59. Thomassen HA, Fuller T, Asefi-Najafabady S, Shiplacoff JAG, Mulembakani PM, et al. (2013) Pathogen-host associations and predicted range shifts of human monkeypox in response to climate change in central africa. PLoS ONE 8: e66071.
60. Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, et al. (2013) Hospital outbreak of middle east respiratory syndrome coronavirus. New England Journal of Medicine 369: 407–416.
61. Blumberg S, Enanoria WTA, Lloyd-Smith JO, Lietman TM, Porco TC, (2014) Identifying postelimination trends for the introduction and transmissibility of measles in the united states. American Journal of Epidemiology 179: 1375–1382.
62. Ferguson NM, Fraser C, Donnelly CA, Ghani AC, Anderson RM, (2004) Public health risk from the avian H5N1 influenza epidemic. Science 304: 1–5.
63. Centers for Disease Control and Prevention (1998) Measles, Mumps, and Rubella–Vaccine Use and Strategies for Elimination of Measles, Rubella, and Congenital Rubella Syndrome and Control of Mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and mortality weekly report 47: 1–57.
64. Wallinga J, Teunis P, (2004) Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures. American Journal of Epidemiology 160: 509–516.
65. Levine RS, Peterson A, Yorita KL, Carroll D, Damon IK, et al. (2007) Ecological niche and geographic distribution of human monkeypox in africa. PLoS ONE 2: e176.